Analyst Ranking
Bottom 9%
#4471 out of 4862 analysts
Average Return
-12.53%
Win Rate
24%14 out of 59
Risk vs Reward
Poor
Good

Mason Carrico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Caredx IncCDNA
+228.02%$7.21$23.65
2023-11-08 -
2024-11-08
Strong Buy
Natera IncNTRA
+154.88%$66.00$168.22
2024-01-29 -
2025-01-29
Strong Buy
Natera IncNTRA
+149.63%$67.50$168.50
2024-01-16 -
2025-01-16
Strong Buy
Caredx IncCDNA
+120.05%$8.28$18.22
2024-04-16 -
2025-04-16
Strong Buy
Guardant Health IncGH
+66.97%$25.52$42.61
2024-05-23 -
2025-04-21
Strong Buy

Mason Carrico Analyst Color

Get additional color on Mason Carrico's coverage of popular stocks

Mason Carrico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Veracyte IncVCYT
4Strong Buy$45.00+47.06%Reiterates
a month ago
Oncocyte CorpOCX
4Hold$4.00+38.89%Reiterates
a month ago
Guardant Health IncGH
5Strong Buy$55.00+29.08%Reiterates
a month ago
Akoya Biosciences IncAKYA
6Hold$1.80+63.64%Downgrades
a month ago
Cytek Biosciences IncCTKB
2Strong Buy$6.00+62.16%Reiterates
a month ago
Staar Surgical CoSTAA
2Hold$17.00+2.84%Reiterates
a month ago
Illumina IncILMN
7Strong Buy$156.00+116.67%Reiterates
a month ago
Establishment Labs Holdings IncESTA
2Strong Buy$52.00+76.81%Reiterates
2 months ago
Caredx IncCDNA
9Strong Buy$40.00+136.13%Reiterates
2 months ago
Pacific Biosciences Of California IncPACB
3Strong Buy$2.50+119.30%Reiterates
2 months ago
Hologic IncHOLX
3Strong Buy$84.00+47.52%Reiterates
3 months ago
Paragon 28 IncFNA
1Hold$13.00-0.69%Downgrades
3 months ago
Myriad Genetics IncMYGN
4Hold$20.00+170.27%Reiterates
3 months ago
Vericel CorpVCEL
1Strong Buy$65.00+59.04%Reiterates
3 months ago
Castle Biosciences IncCSTL
7Strong Buy$41.00+93.95%Reiterates
4 months ago
10x Genomics IncTXG
5Strong Buy$30.00+290.63%Reiterates
6 months ago
Natera IncNTRA
4Strong Buy$125.00-12.11%Reiterates
8 months ago
Neogenomics IncNEO
1Strong Buy$19.00+98.33%Reiterates
9 months ago
Dermtech IncDMTKQ
4Hold$1.50N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.